ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「過敏性腸症候群(IBS)の治療最前線:低FODMAP食、プロバイオティクス、薬物療法まで全解説」の検索結果

11,513 件中 10 件を表示 (4161 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
("irritable bowel syndrome"[MeSH] OR IBS) AND ("diet, FODMAP"[MeSH] OR "low FODMAP" OR "probiotics"[MeSH] OR probiotic OR "drug therapy"[MeSH:NoExp] OR pharmacotherapy OR treatment) AND (therapy OR management)

💡 IBS治療の3本柱(低FODMAP食・プロバイオティクス・薬物療法)を包括的に検索するクエリに変換

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Diet, fibers, and probiotics for irritable bowel syndrome.

    Adelina Nicoleta Galica, Reitano Galica, Dan Lucian Dumitrașcu 他 · Journal of medicine and life · 2022

    Many aspects make irritable bowel syndrome (IBS) challenging for both patients and physicians. The unclear pathogenesis with many pathways to be explored, bothering symptoms that affect the quality of life, and many subtypes of the condition are only a few reasons that make IBS difficult to control and obtain satisfactory results. Treatment options start with general advice for lifestyle, continue…

    📄 PubMed で読む (PMID: 35419092)
  • Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.

    Peter C Konturek, T Brzozowski, S J Konturek 他 · Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2011

    Stress, which is defined as an acute threat to homeostasis, shows both short- and long-term effects on the functions of the gastrointestinal tract. Exposure to stress results in alterations of the brain-gut interactions ("brain-gut axis") ultimately leading to the development of a broad array of gastrointestinal disorders including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) a…

    📄 PubMed で読む (PMID: 22314561)
  • Low-FODMAP Diet for Irritable Bowel Syndrome: Insights from Microbiome.

    Haoshuai Zhang, Qi Su · Nutrients · 2025

    Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder characterized by chronic abdominal pain, bloating, and altered bowel habits. Low-FODMAP diets, which involve restricting fermentable oligosaccharides, disaccharides, monosaccharides, and polyols, have emerged as an effective dietary intervention for alleviating IBS symptoms. This review paper aims to synthesize current insight…

    📄 PubMed で読む (PMID: 39940404)
  • British Society of Gastroenterology guidelines on the management of irritable bowel syndrome.

    Dipesh H Vasant, Peter A Paine, Christopher J Black 他 · Gut · 2021

    Irritable bowel syndrome (IBS) remains one of the most common gastrointestinal disorders seen by clinicians in both primary and secondary care. Since publication of the last British Society of Gastroenterology (BSG) guideline in 2007, substantial advances have been made in understanding its complex pathophysiology, resulting in its re-classification as a disorder of gut-brain interaction, rather t…

    📄 PubMed で読む (PMID: 33903147)
  • Antibiotics and Probiotics for Irritable Bowel Syndrome.

    Vivek C Goodoory, Alexander C Ford · Drugs · 2023

    Irritable bowel syndrome (IBS) is a disorder of a gut-brain interaction characterised by abdominal pain and a change in stool form or frequency. Current symptom-based definitions and the classification of IBS promote heterogeneity amongst patients, meaning that there may be several different pathophysiological abnormalities leading to similar symptoms. Although our understanding of IBS is incomple…

    📄 PubMed で読む (PMID: 37184752)
  • Bifidobacteria and Their Health-Promoting Effects.

    Claudio Hidalgo-Cantabrana, Susana Delgado, Lorena Ruiz 他 · Microbiology spectrum · 2017

    Bifidobacteria are members of the intestinal microbiota of mammals and other animals, and some strains are able to exert health-promoting effects. The genus Bifidobacterium belongs to the Actinobacteria phylum. Firmicutes, Bacteroidetes, and Actinobacteria constitute the most abundant phyla in the human intestinal microbiota, Firmicutes and Bacteroidetes being predominant in adults, and Actinobact…

    📄 PubMed で読む (PMID: 28643627)
  • The pros, cons, and many unknowns of probiotics.

    Jotham Suez, Niv Zmora, Eran Segal 他 · Nature medicine · 2019

    Consumption of over-the-counter probiotics for promotion of health and well-being has increased worldwide in recent years. However, although probiotic use has been greatly popularized among the general public, there are conflicting clinical results for many probiotic strains and formulations. Emerging insights from microbiome research enable an assessment of gut colonization by probiotics, strain-…

    📄 PubMed で読む (PMID: 31061539)
  • The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.

    Youhe Wu, Yuetong Li, Qi Zheng 他 · Nutrients · 2024

    Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with gut microbiota imbalance playing a significant role. There are increasing numbers of research studies exploring treatment options involving probiotics, prebiotics, synbiotics, and fecal microbiota transplantation (FMT), but it is still uncertain which treatment option is superior. The research was conducted on various databa…

    📄 PubMed で読む (PMID: 38999862)
  • Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review.

    Justyna Paulina Wielgosz-Grochowska, Nicole Domanski, Małgorzata Ewa Drywień 他 · Nutrients · 2022

    Small intestinal bacterial overgrowth (SIBO) is highly prevalent in irritable bowel syndrome (IBS). The eradication of bacterial overgrowth with antibiotics is the first-line treatment. However, focusing only on the antimicrobial effects without taking care to improve lifestyle factors, especially dietary patterns, may predispose patients to intestinal microbiota dysfunction. The objective of this…

    📄 PubMed で読む (PMID: 36014888)
  • Evaluation of the efficacy of probiotics as treatment in irritable bowel syndrome.

    Cristina Ruiz-Sánchez, Blanca Escudero-López, María-Soledad Fernández-Pachón 他 · Endocrinologia, diabetes y nutricion · 2024

    Irritable bowel syndrome (IBS) is a gastrointestinal functional disorder mainly characterised by abdominal pain, bloating and altered bowel habits. Dysbiosis might seem to be involved in the pathogenesis of the disease. Probiotics represent a potential treatment, since these could favour the functional microbiota and improve symptoms. The aim was to review the effectiveness of the use of probiotic…

    📄 PubMed で読む (PMID: 38331656)